![](https://www.adcreviews.com/wp-content/uploads/2022/07/Lunsumio-300x150.jpeg)
Roche Lunsumio Receives Priority Review From US FDA
Basel, 6 July 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s
Basel, 6 July 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s